Analysis of Ivacaftor drug approval for cystic fibrosis patients with gating mutations.
Cystic fibrosis is an inherited monogenetic disorder that leads to chronic respiratory and lung infections. These infections result in decreased quality of life in patients. Quality of life (QOL) can be attributed to many disease characteristics such as hospitalization, organ transplant, depression,...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Royal St. George's College
2021-08-01
|
| سلاسل: | The Young Researcher |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://www.theyoungresearcher.com/papers/nemirajaiah.pdf |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|